Documents & Downloads

CDK9-IN-31

CDK9 Inhibitor

CDK9-IN-31 is a selective inhibitor of cyclin-dependent kinase 9 (CDK9), which plays a critical role in regulating transcription and cell proliferation. By inhibiting CDK9, this compound demonstrates significant anti-cancer activity through the suppression of cancer cell growth. Its potential applications extend to cancer research, providing valuable insights into therapeutic strategies targeting transcriptional regulation in malignancies.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	2991074-93-0
Applications	CDK9 Inhibitor
Formula	C₂₄H₃₃ClN₆O₂S
Molecular Weight	505.08
SMILES	OC[C@@H](C)N[C@@H](CC1)CC[C@H]1NC2=CC(C3=CSC(NCC4(CCOCC4)C#N)=N3)=C(Cl)C=N2

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.